Tale of Two Pages: WSJ Coverage of Drug Pricing

  • by: |
  • 12/15/2015
Jeanne Whelan’s article “Why the US Pays More for Than Other Countries for Drugs” is misleading and inaccurate. Whelan overstates the price gap in several ways. She ignores that vast majority of medicines that are launched at the same or lower price in the United States. She cherry picked countries with lowest prices and excluded those with higher prices such as Ireland, Belgium and Germany. Finally, she focuses on older (mostly) cancer drugs that been price controlled for a decade in order to overstate the difference even more. Whelan assumes that drug prices increase cost and reduce access. It turns out most countries – including Norway, UK and Canada – spend more on cancer care as a share of total health care spending as America. Adjusting cancer drug prices to EU levels would cut total health spending in the US by .33 percent. Applying price controls would mean more Americans would die from cancer and other serious illnesses such as heart disease. A study of European cancer spending and mortality concluded countries that with faster access and increased spending on new drugs had a 17 percent decrease in cancer deaths, mortality, compared to 8 percent in such as Canada and UK that Whelan selected. 1 Price controls are also associated with more heart attack deaths. Other countries that spend less on new drugs, spend more on health care and have more premature death.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog